Manufacturer copay assistance · Imjudo (J9347) · AstraZeneca
$0 · Maximum benefit $25,000 · Covers drug and administration costs
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Imjudo — the program's cap applies against the patient share CareCost calculates.
Yes — AstraZeneca Access 360 Co-pay Program from AstraZeneca. $0. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
$0 Maximum benefit: $25,000. Covers drug and administration costs
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.